Menu
Search
|

Menu

Close
X

Luminex Corp LMNX.OQ (NASDAQ Stock Exchange Global Select Market)

19.84 USD
+0.12 (+0.61%)
As of Feb 20
chart
Previous Close 19.72
Open 19.66
Volume 148,171
3m Avg Volume 82,007
Today’s High 19.99
Today’s Low 19.50
52 Week High 22.41
52 Week Low 17.68
Shares Outstanding (mil) 44.05
Market Capitalization (mil) 874.04
Forward P/E 29.11
Dividend (Yield %) 0.06 ( 1.21 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
3.00 Mean rating from 7 analysts

KEY STATS

Revenue (mm, USD)
FY17
307
FY16
271
FY15
238
EPS (USD)
FY17
0.682
FY16
0.325
FY15
0.858
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
29.11
35.76
Price to Sales (TTM)
vs sector
2.85
8.59
Price to Book (MRQ)
vs sector
1.96
5.23
Price to Cash Flow (TTM)
vs sector
16.79
26.13
Total Debt to Equity (MRQ)
vs sector
--
15.32
LT Debt to Equity (MRQ)
vs sector
--
11.95
Return on Investment (TTM)
vs sector
6.88
13.59
Return on Equity (TTM)
vs sector
6.99
15.20

EXECUTIVE LEADERSHIP

G. Walter Loewenbaum
Independent Chairman of the Board, Since 2002
Salary: --
Bonus: --
Nachum Shamir
President, Chief Executive Officer, Director, Since 2014
Salary: $636,000.00
Bonus: --
Harriss Currie
Chief Financial Officer, Senior Vice President - Finance, Treasurer, Since 2013
Salary: $381,275.00
Bonus: --
Richard Rew
Senior Vice President, General Counsel, Secretary, Since 2015
Salary: $327,500.00
Bonus: --
Todd Bennett
Senior Vice President - Global Sales and Customer Operations, Since 2016
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Advanced Medical Equipment & Technology
Address:

12212 Technology Blvd, 512-219-8
AUSTIN   TX   78727

Phone: +1512.2494741

Luminex Corporation develops, manufactures and sells biological testing technologies with applications throughout the diagnostics, pharmaceutical and life sciences industries. The Company's products are focused on the molecular diagnostic testing market, which includes human genetics, personalized medicine and infectious disease segments. The Company has a range of instruments using its xMAP technology, which includes its LUMINEX 100/200 systems offer 100-plex testing; the Company's FLEXMAP 3D system is its high-throughput, 500-plex testing system, and its MAGPIX system provides 50-plex testing using imaging rather than flow cytometry. By using its xMAP technology, the end users are able to generate multiple simultaneous results per sample. The Company primarily serves the diagnostics, pharmaceutical and life sciences industries by marketing products, including its testing equipment and assays, to a range of testing laboratories.

SPONSORED STORIES